HilleVax (HLVX)

HLVX was delisted on the 16th of September, 2025.

• Sector: Healthcare
• Industry: Biotechnology

About: HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Employees: 14